Plasma and cerebrospinal fluid ABeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care setting-Reference-Cited by-同舟云学术

Plasma and cerebrospinal fluid ABeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care setting

Published:2021-02-10 Issue:2 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Kokkinou Michelle¹,Beishon Lucy C²,Smailagic Nadja³,Noel-Storr Anna H⁴,Hyde Chris⁵,Ukoumunne Obioha⁶,Worrall Rosemary E⁷,Hayen Anja⁸,Desai Meera⁹,Ashok Abhishekh Hulegar¹¹⁰,Paul Eleanor J¹¹¹,Georgopoulou Aikaterini¹²,Casoli Tiziana¹³,Quinn Terry J¹⁴,Ritchie Craig W¹⁵

Affiliation:

1. MRC London Institute of Medical Sciences; Imperial College London; London UK

2. Department of Cardiovascular Sciences; University of Leicester; Leicester UK

3. Institute of Public Health; University of Cambridge ; Cambridge UK

4. Radcliffe Department of Medicine; University of Oxford ; Oxford UK

5. Exeter Test Group; College of Medicine and Health, University of Exeter Medical School, University of Exeter; Exeter UK

6. NIHR CLAHRC South West Peninsula (PenCLAHRC); University of Exeter Medical School; Exeter UK

7. University of Oxford Medical School; Oxford UK

8. Department of Psychology and Clinical Language Sciences; University of Reading; Reading UK

9. Department of Experimental Psychology; University of Oxford; Oxford UK

10. Department of Psychosis Studies; Institute of Psychiatry, Psychology and Neuroscience, King's College ; London UK

11. Institute of Clinical Sciences (ICS), Faculty of Medicine; Imperial College London; London UK

12. Department of Surgery and Cancer; Imperial College London; London UK

13. Center for Neurobiology of Aging; IRCCS INRCA; Ancona Italy

14. Institute of Cardiovascular and Medical Sciences; University of Glasgow; Glasgow UK

15. Centre for Clinical Brain Sciences; University of Edinburgh; Edinburgh UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference142 articles.

1. Cerebrospinal fluid biomarkers in patients with frontotemporal dementia spectrum: a single-center study;Abu-Rumeileh;Journal of Alzheimer's Disease,2018

2. CSF tau, Aβ42 and MHPG differentiate dementia with Lewy bodies from Alzheimer's disease;Aerts;Journal of Alzheimer's Disease,2011

3. Cerebrospinal fluid Aβ40 is similarly reduced in patients with frontotemporal lobar degeneration and Alzheimer's disease;Baldeiras;Journal of the Neurological Sciences,2015

4. CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies;Bibl;Journal of Neural Transmission,2006

5. Reduced CSF carboxyterminally truncated Aβ peptides in frontotemporal lobe degenerations;Bibl;Journal of Neural Transmission,2007

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time trends in Alzheimer’s disease mortality attributable to metabolic risks and smoking in China from 1990 to 2019: an age-period-cohort analysis;Frontiers in Aging Neuroscience;2024-07-03

2. Guideline summary: assessment, diagnosis, care and support for people with dementia and their carers [Scottish Intercollegiate Guidelines Network SIGN Guideline 168];Age and Ageing;2024-07

3. Scottish Intercollegiate Guidelines Network Guidance on Dementia: The Investigation of Suspected Dementia (SIGN 168) with Focus on Biomarkers—Executive Summary;Thrombosis and Haemostasis;2024-05-24

4. Use of Modern Classification Systems for the Complex Diagnostics of Alzheimer’s Disease;Neuroscience and Behavioral Physiology;2024-05

5. Alcohol Use Disorder and Dementia: A Review;Alcohol Research: Current Reviews;2024